Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew M Scott

Showing results (211-220 of 395) with videos related to

Pageof 40
Sort By:
Cancer Research|August 3, 2005
Concurrent binding of anti-EphA3 antibody and ephrin-A5 amplifies EphA3 signaling and downstream responses: potential as EphA3-specific tumor-targeting reagentsChristopher Vearing, Fook-Thean Lee, Sabine Wimmer-Kleikamp, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 24, 2011
Histopathological correlation of (11)C-choline PET scans for target volume definition in radical prostate radiotherapyJoe H Chang, Daryl Lim Joon, Sze Ting Lee, et al.
Nuclear Medicine and Biology|February 17, 2012
Radiolabelling and evaluation of novel haloethylsulfoxides as PET imaging agents for tumor hypoxiaEvelyn Laurens, Shinn Dee Yeoh, Angela Rigopoulos, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 4, 2006
Correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in gliomas using 18F-fluoromisonidazole, 18F-FDG PET, and immunohistochemical studiesLawrence M Cher, Carmel Murone, Nathan Lawrentschuk, et al.
Molecular Oncology|May 26, 2017
K-Ras mutation and amplification status is predictive of resistance and high basal pAKT is predictive of sensitivity to everolimus in biliary tract cancer cell linesYvonne Yeung, David K Lau, Fiona Chionh, et al.
Annals of Surgery|August 10, 2002
Evaluation of 18 F-fluorodeoxyglucose positron emission tomography and computed tomography with histopathologic correlation in the initial staging of head and neck cancerAnthony Hannah, Andrew M Scott, Henri Tochon-Danguy, et al.
Nuclear Medicine and Biology|April 29, 2014
Radiolabelling and evaluation of a novel sulfoxide as a PET imaging agent for tumor hypoxiaEvelyn Laurens, Shinn Dee Yeoh, Angela Rigopoulos, et al.
Journal of Nuclear Medicine Technology|February 26, 2005
Radiation dose to PET technologists and strategies to lower occupational exposureFiona O Roberts, Dishan H Gunawardana, Kunthi Pathmaraj, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 5, 2003
Targeting primary human Ph(+) B-cell precursor leukemia-engrafted SCID mice using radiolabeled anti-CD19 monoclonal antibodiesPaul Mitchell, Fook-Thean Lee, Cathrine Hall, et al.
Radiology|September 11, 2010
Global trends in hybrid imagingHedvig Hricak, Byung Ihn Choi, Andrew M Scott, et al.
Pageof 40

Showing results (211-220 of 395) with videos related to

Sort By:
Pageof 40
Cancer Research|August 3, 2005
Concurrent binding of anti-EphA3 antibody and ephrin-A5 amplifies EphA3 signaling and downstream responses: potential as EphA3-specific tumor-targeting reagentsChristopher Vearing, Fook-Thean Lee, Sabine Wimmer-Kleikamp, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 24, 2011
Histopathological correlation of (11)C-choline PET scans for target volume definition in radical prostate radiotherapyJoe H Chang, Daryl Lim Joon, Sze Ting Lee, et al.
Nuclear Medicine and Biology|February 17, 2012
Radiolabelling and evaluation of novel haloethylsulfoxides as PET imaging agents for tumor hypoxiaEvelyn Laurens, Shinn Dee Yeoh, Angela Rigopoulos, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 4, 2006
Correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in gliomas using 18F-fluoromisonidazole, 18F-FDG PET, and immunohistochemical studiesLawrence M Cher, Carmel Murone, Nathan Lawrentschuk, et al.
Molecular Oncology|May 26, 2017
K-Ras mutation and amplification status is predictive of resistance and high basal pAKT is predictive of sensitivity to everolimus in biliary tract cancer cell linesYvonne Yeung, David K Lau, Fiona Chionh, et al.
Annals of Surgery|August 10, 2002
Evaluation of 18 F-fluorodeoxyglucose positron emission tomography and computed tomography with histopathologic correlation in the initial staging of head and neck cancerAnthony Hannah, Andrew M Scott, Henri Tochon-Danguy, et al.
Nuclear Medicine and Biology|April 29, 2014
Radiolabelling and evaluation of a novel sulfoxide as a PET imaging agent for tumor hypoxiaEvelyn Laurens, Shinn Dee Yeoh, Angela Rigopoulos, et al.
Journal of Nuclear Medicine Technology|February 26, 2005
Radiation dose to PET technologists and strategies to lower occupational exposureFiona O Roberts, Dishan H Gunawardana, Kunthi Pathmaraj, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 5, 2003
Targeting primary human Ph(+) B-cell precursor leukemia-engrafted SCID mice using radiolabeled anti-CD19 monoclonal antibodiesPaul Mitchell, Fook-Thean Lee, Cathrine Hall, et al.
Radiology|September 11, 2010
Global trends in hybrid imagingHedvig Hricak, Byung Ihn Choi, Andrew M Scott, et al.
Pageof 40